Form 4: Morningstar Chair Mansueto Sells 8,039 Shares

Morningstar Executive Chairman Joseph D. Mansueto sold 8,039 shares under a Rule 10b5-1 plan at ~$211–$213, retaining about 14.73 million shares.

Summary

• Executive Chairman, Director, and 10% owner Joseph D. Mansueto sold 8,039 Morningstar (MORN) shares across two transactions on 11/14/2025 and 11/17/2025 under a Rule 10b5-1 plan adopted on 11/15/2024.
• 11/14/2025: Sold 6,969 shares at a weighted average price of $213.3175 (trade range: $212.9850–$213.8000).
• 11/17/2025: Sold 1,070 shares at a weighted average price of $211.1233 (trade range: $210.9500–$211.6600).
• Direct holdings after the transactions: 8,631,417 shares.
• Indirect holdings via trusts: 5,948,127 shares (grantor retained annuity trusts) and 150,000 shares (children’s trusts), totaling 6,098,127 indirect shares.
• Total reported beneficial ownership after the sales: approximately 14,729,544 shares (direct + indirect).
• Sales were executed in multiple trades, with the reporting person undertaking to provide detailed trade data upon request to the SEC staff, the company, or shareholders.
• Form signed by attorney-in-fact on 11/18/2025.

Sentiment

Score: 5

Explanation: Neutral: small, pre-planned insider sale with negligible impact on overall ownership; no operational or financial guidance implications.

Positives

• Sales conducted under a pre-established Rule 10b5-1 trading plan (adopted 11/15/2024), indicating pre-planned, non-opportunistic activity.
• Very small size relative to holdings: 8,039 shares sold vs. ~14.73 million beneficially owned post-transaction (~0.06%).
• Executive Chairman retains a substantial stake (8,631,417 direct; 6,098,127 indirect), maintaining strong alignment with shareholders.
• Transparent disclosure of price ranges and willingness to provide detailed trade data upon request.

Negatives

• Insider sale by the Executive Chairman can be perceived negatively by some investors despite being pre-planned.
• No offsetting insider purchases disclosed.

Future Outlook

No forward-looking guidance. Sales were conducted under a pre-existing Rule 10b5-1 plan and may continue per that plan’s parameters.

Management Comments

• Sales were effected pursuant to a Rule 10b5-1 trading plan adopted on 11/15/2024.
• Transactions were executed in multiple trades; the weighted average prices are disclosed and detailed trade information will be provided upon request.
• Indirect holdings are held in grantor retained annuity trusts for the reporting person and children, and in separate trusts for the children.

Industry Context

Routine insider sales under Rule 10b5-1 plans are common among U.S. public companies and do not necessarily indicate a view on near-term fundamentals. For financial data peers (e.g., FactSet, MSCI, S&P Global), similar founder/executive sales are often part of ongoing diversification and estate planning.

Comparison to Industry Standards

• Sale magnitude is minimal (~0.06% of total beneficial ownership), consistent with routine 10b5-1 programmatic sales seen at peer data/analytics firms (e.g., MSCI, S&P Global, FactSet) where executives often sell small portions periodically.
• Use of Rule 10b5-1 aligns with best practices for governance and trading compliance, reducing concerns about opportunistic timing compared to ad hoc sales.

Stakeholder Impact

• No dilution; shares sold were secondary from an insider.
• Marginal increase in public float; negligible ownership change given the small size of the sale.
• Continued significant insider ownership supports alignment with long-term shareholders.

Next Steps

• Provide detailed trade information upon request to SEC staff, Morningstar, or shareholders, as undertaken in the form.

Key Dates

Keywords

Morningstar, MORN, Form 4, insider trading, Joseph D. Mansueto, Rule 10b5-1, Executive Chairman, beneficial ownership, insider sale, trust holdings